ZA200900388B - Compositions and methods for the treatment of mucositis - Google Patents

Compositions and methods for the treatment of mucositis

Info

Publication number
ZA200900388B
ZA200900388B ZA200900388A ZA200900388A ZA200900388B ZA 200900388 B ZA200900388 B ZA 200900388B ZA 200900388 A ZA200900388 A ZA 200900388A ZA 200900388 A ZA200900388 A ZA 200900388A ZA 200900388 B ZA200900388 B ZA 200900388B
Authority
ZA
South Africa
Prior art keywords
mucositis
compositions
treatment
methods
Prior art date
Application number
ZA200900388A
Other languages
English (en)
Inventor
C Eric Schwartz
Per Gjorstrup
Original Assignee
Resolvyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolvyx Pharmaceuticals Inc filed Critical Resolvyx Pharmaceuticals Inc
Publication of ZA200900388B publication Critical patent/ZA200900388B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200900388A 2006-07-19 2009-01-16 Compositions and methods for the treatment of mucositis ZA200900388B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83186606P 2006-07-19 2006-07-19

Publications (1)

Publication Number Publication Date
ZA200900388B true ZA200900388B (en) 2010-03-31

Family

ID=38617335

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900388A ZA200900388B (en) 2006-07-19 2009-01-16 Compositions and methods for the treatment of mucositis

Country Status (14)

Country Link
US (1) US20100035989A1 (id)
EP (1) EP2049099A1 (id)
JP (1) JP2009545527A (id)
KR (1) KR20090040323A (id)
CN (1) CN101528218A (id)
AU (1) AU2007275658B2 (id)
BR (1) BRPI0714562A2 (id)
CA (1) CA2658361C (id)
IL (1) IL196465A0 (id)
MX (1) MX2009000657A (id)
RU (1) RU2009101324A (id)
SG (1) SG173397A1 (id)
WO (1) WO2008011085A1 (id)
ZA (1) ZA200900388B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3846801A (en) 2000-02-16 2001-08-27 Brigham & Womens Hospital Aspirin-triggered lipid mediators
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US8481772B2 (en) * 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US8324277B2 (en) 2007-08-01 2012-12-04 University of Pittsburgh—of the Commonwealth System of Higher Education Nitrated-fatty acids modulation of type II diabetes
EP2214660A2 (en) * 2007-10-12 2010-08-11 Resolvyx Pharmaceuticals, Inc. Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions
CA2729053A1 (en) 2008-05-01 2009-11-05 Bruce A. Freeman Vinyl substituted fatty acids
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
CN102099024B (zh) 2008-06-19 2015-11-25 犹他大学研究基金会 硝化脂质在毒性医疗疗法的副作用的治疗上的用途
US20120122816A1 (en) * 2009-02-05 2012-05-17 Resolvyx Pharmaceuticals, Inc. Compositions and methods for organ preservation
EP2415748A4 (en) 2009-02-20 2013-08-07 Univ Tokyo NEW INFLAMMATORY COMPOUNDS
JP2013500966A (ja) * 2009-07-31 2013-01-10 ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション 抗炎症剤としての脂肪酸
EP2483233A4 (en) 2009-10-02 2013-08-14 Complexa Inc HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
EP2744491B1 (en) 2011-08-19 2020-07-29 The University of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
JP2015508065A (ja) * 2012-02-03 2015-03-16 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 抗炎症薬としての脂肪酸
CN103417471A (zh) * 2012-05-22 2013-12-04 吴升华 一种治疗湿疹等皮肤炎症的脂氧素乳膏
US20160199338A1 (en) 2013-08-19 2016-07-14 Enzychem Lifesciences Corporation Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis
JP6609850B2 (ja) * 2014-01-24 2019-11-27 国立大学法人京都大学 希少脂肪酸を含む抗炎症剤
WO2015176012A1 (en) 2014-05-15 2015-11-19 Enzychem Lifesciences Corporation Methods for treating leukopenia and thrombocytopenia
DK3303339T3 (da) 2015-07-07 2021-04-12 H Lundbeck As Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme
EP3355879A4 (en) 2015-10-02 2019-05-22 Complexa, Inc. PREVENTION, TREATMENT AND INVERSION OF DISEASE USING THERAPEUTICALLY EFFECTIVE AMOUNTS OF ACTIVATED FATTY ACIDS
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
JP2021526134A (ja) 2018-05-25 2021-09-30 イマラ インク． ６−［（３Ｓ，４Ｓ）−４−メチル−ｌ−（ピリミジン−２−イルメチル）ピロリジン−３−イル］−３−テトラヒドロピラン−４−イル−７Ｈ−イミダゾ［ｌ，５−Ａ］ピラジン−８−オンの一水和物および結晶形態

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576758A (en) * 1984-06-01 1986-03-18 The Upjohn Company Anti-inflammatory lipoxin B analogs
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
CA2645558C (en) * 1999-03-18 2012-05-15 Brigham And Women's Hospital Regulation of phospholipase d activity
AU3846801A (en) * 2000-02-16 2001-08-27 Brigham & Womens Hospital Aspirin-triggered lipid mediators
EP1268393A2 (en) * 2000-03-20 2003-01-02 Trustees Of Boston University Lipoxin analogs and methods for the treatment of periodontal disease
ATE412448T1 (de) * 2001-03-02 2008-11-15 Brigham & Womens Hospital Lipoxin analoge als neue inhibitoren der angiogenese
WO2003048148A2 (en) * 2001-12-03 2003-06-12 Novozymes A/S Statin-like compounds
EP1458373A1 (en) * 2001-12-18 2004-09-22 The Brigham and Women's Hospital Use of lipoxin analogs to promote cell defense against gram-negative infections
WO2003053423A2 (en) * 2001-12-18 2003-07-03 The Brigham And Women's Hospital Inhibition or prevention of infection by bacteria with epa, dha or analogs
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
ES2527753T3 (es) * 2002-04-01 2015-01-29 University Of Southern California Eicosanoides trihidroxi poliinsaturados
AU2003238240A1 (en) * 2002-06-17 2003-12-31 Resolvyx Pharmaceuticals ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
US7759395B2 (en) * 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
ES2700133T3 (es) * 2002-08-12 2019-02-14 Brigham & Womens Hospital Resolvinas: modelos biológicos para intervenciones terapéuticas
WO2004110426A1 (en) * 2003-06-01 2004-12-23 Petasis Nicos A Modulation of airway inflammation in patients with cystic fibrosis and related diseases
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
US7884131B2 (en) * 2004-11-19 2011-02-08 Martek Biosciences, Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
US20060293288A1 (en) * 2005-01-07 2006-12-28 Serhan Charles N Use of resolvins to treat gastrointestinal diseases

Also Published As

Publication number Publication date
SG173397A1 (en) 2011-08-29
AU2007275658B2 (en) 2011-09-01
US20100035989A1 (en) 2010-02-11
MX2009000657A (es) 2009-05-28
CN101528218A (zh) 2009-09-09
CA2658361C (en) 2013-04-23
KR20090040323A (ko) 2009-04-23
JP2009545527A (ja) 2009-12-24
AU2007275658A1 (en) 2008-01-24
WO2008011085A1 (en) 2008-01-24
IL196465A0 (en) 2009-11-18
CA2658361A1 (en) 2008-01-24
EP2049099A1 (en) 2009-04-22
BRPI0714562A2 (pt) 2013-04-02
RU2009101324A (ru) 2010-07-27

Similar Documents

Publication Publication Date Title
ZA200900388B (en) Compositions and methods for the treatment of mucositis
HK1134679A1 (zh) 用於治療感染的組合物和方法
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
SI2185581T1 (sl) Postopki in sestavki, uporabni v zdravljenju mukozitisa
EP1969147A4 (en) METHODS AND COMPOSITIONS BASED ON MICRO-RNA AND APPLYING TO THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS
HK1125868A1 (en) Compositions and methods for treating bone
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
ZA200808431B (en) Fungicidal compositions and methods of using the same
IL190520A0 (en) Compositions and methods for treatment of autoimmune
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
PL2056675T3 (pl) Metody leczenia zapalenia błony śluzowej jamy ustnej
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
EP1937075A4 (en) SYNERGIC COMPOSITION AND METHOD OF USE
PT2185581E (pt) Processos e composições úteis no tratamento de mucosite
GB0909297D0 (en) Composition for the treatment of skin conditions
IL187405A0 (en) Methods and compositions for the treatment of pain
EP2124968A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE ATROPHY
GB0718918D0 (en) Compositions and methods for treating skin conditions
EP2285398A4 (en) METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0504657D0 (en) Compositions and methods of treatment